ba0001pp484 | Other diseases of bone and mineral metabolism | ECTS2013
Silva Ana Maria
, Moreira Ana Carolina
, Santos Maria Sancha
, Albuquerque Anabela
, Ferreira Izilda
, Gil Paulo
, Isidoro Jorge
, Videira Romeu
, Carvalho Rui
, Sardao Vilma
Introduction: Osteocytes play a major role in the bone remodelling unit (BRU). Thus, we hypothesize that mitochondrial bioenergetics impairment and mitochondrial/peroxisomal fatty acid β-oxidation unbalance is a cause of osteocytes metabolic decline during 17β-estradiol (E2) reduction. E2 and a phytochemical substitute, coumestrol (COU) were used (30 mg/kg during 24 h in ovariectomized rats in order to compare bone loss with sham-operated animal...